Skip to search formSkip to main contentSkip to account menu

Cyclin Dependent Kinase Inhibitor P276

Known as: P276 
National Institutes of Health

Related topics

Related topics

1 relation
P276-00

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract P276: Activity Tracker Increases Daily Step Count Post-Cardiac Rehabilitation Compared to Placebo Device
Introduction: Despite optimal levels of physical activity (PA) among patients immediately post-cardiac rehabilitation, little is… 
2016
2016
P276 Predicting latent classes of food allergy risk-taking behaviors among adolescents and young adults
Review
2016
Review
2016
Abstract P276: Self-perceived Diet Quality, Obesity Status, and Household Food Purchasing Behaviors Among US Adults
Introduction: Previous research suggests that consumer food purchasing behaviors (e.g. food venue choice, food purchasing… 
2015
2015
P276 The Prevalence of Ticarcillin Hyper-susceptible Pseudmonoas aeruginosa isolates from Non Cystic Fibrosis Bronchiectasis patients compared to patients with Cystic Fibrosis and controls
Background and aims Pseudomonas aeruginosa (PsA) is associated with considerable morbidity and mortality in Non-Cystic Fibrosis… 
2013
2013
Abstract 3437: P276, a cyclin-dependent kinase inhibitor with antitumor activity against high-risk human cervical cancer.
Cervical cancer is the third most common cancer worldwide in women. While preventive vaccines have been approved for cervical… 
2012
2012
CDK-4 Inhibitor P276 Sensitizes Pancreatic Cancer Cells to Gemcitabine-Induced Apoptosis
Despite advances in molecular pathogenesis, pancreatic cancer remains a major unsolved health problem. It is a rapidly invasive… 
2012
2012
Preclinical Development CDK-4 Inhibitor P 276 Sensitizes Pancreatic Cancer Cells to Gemcitabine-Induced Apoptosis
Despite advances inmolecular pathogenesis, pancreatic cancer remains amajor unsolved health problem. It is a rapidly invasive… 
2011
2011
P276 - Les apports épidémiologiques du prestataire de service aux centre initiateurs sur le traitement par pompe à insuline
2011
2011
Abstract P276: Cardiac-Specific Knockout NF-kB Mice Resist Dysfunction Induced by Global Ischemia-Reperfusion
Subjective: Nuclear factor Kappa B (NF-kB) is a pluripotent transcriptional factor that has been implicated as mediator of… 
2010
2010
Abstract P6-15-05: A Cyclin-Dependent Kinase Inhibitor P276 Inhibits Growth of Breast Cancer Cell Lines Including Basal-Type/Triple-Negative Alone and in Combination with Chemotherapeutic Drugs
Background: Development of novel agents and drug combinations are urgently needed for the treatment of breast cancer especially… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)